197 related articles for article (PubMed ID: 30665434)
1. A decade of antiretroviral therapy in Uganda: what are the emerging causes of death?
Kiragga AN; Mubiru F; Kambugu AD; Kamya MR; Castelnuovo B
BMC Infect Dis; 2019 Jan; 19(1):77. PubMed ID: 30665434
[TBL] [Abstract][Full Text] [Related]
2. Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort.
Castelnuovo B; Manabe YC; Kiragga A; Kamya M; Easterbrook P; Kambugu A
Clin Infect Dis; 2009 Sep; 49(6):965-72. PubMed ID: 19673615
[TBL] [Abstract][Full Text] [Related]
3. Causes and outcome of hospitalization among HIV-infected adults receiving antiretroviral therapy in Mulago hospital, Uganda.
Namutebi AM; Kamya MR; Byakika-Kibwika P
Afr Health Sci; 2013 Dec; 13(4):977-85. PubMed ID: 24940321
[TBL] [Abstract][Full Text] [Related]
4. Ten years of antiretroviral therapy: Incidences, patterns and risk factors of opportunistic infections in an urban Ugandan cohort.
Weissberg D; Mubiru F; Kambugu A; Fehr J; Kiragga A; von Braun A; Baumann A; Kaelin M; Sekaggya-Wiltshire C; Kamya M; Castelnuovo B
PLoS One; 2018; 13(11):e0206796. PubMed ID: 30383836
[TBL] [Abstract][Full Text] [Related]
5. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.
Liechty CA; Solberg P; Were W; Ekwaru JP; Ransom RL; Weidle PJ; Downing R; Coutinho A; Mermin J
Trop Med Int Health; 2007 Aug; 12(8):929-35. PubMed ID: 17697087
[TBL] [Abstract][Full Text] [Related]
6. Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study.
Gupta-Wright A; Corbett EL; Wilson D; van Oosterhout JJ; Dheda K; Huerga H; Peter J; Bonnet M; Alufandika-Moyo M; Grint D; Lawn SD; Fielding K
PLoS Med; 2019 Apr; 16(4):e1002776. PubMed ID: 30951533
[TBL] [Abstract][Full Text] [Related]
7. Temporal trends in death causes in adults attending an urban HIV clinic in Uganda: a retrospective chart review.
Cox JA; Kiggundu D; Elpert L; Meintjes G; Colebunders R; Alamo S
BMJ Open; 2016 Jan; 6(1):e008718. PubMed ID: 26739722
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.
Hamers RL; Wallis CL; Kityo C; Siwale M; Mandaliya K; Conradie F; Botes ME; Wellington M; Osibogun A; Sigaloff KC; Nankya I; Schuurman R; Wit FW; Stevens WS; van Vugt M; de Wit TF;
Lancet Infect Dis; 2011 Oct; 11(10):750-9. PubMed ID: 21802367
[TBL] [Abstract][Full Text] [Related]
9. Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings.
Lawn SD; Harries AD; Wood R
Curr Opin HIV AIDS; 2010 Jan; 5(1):18-26. PubMed ID: 20046144
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.
Rajasingham R; Meya DB; Greene GS; Jordan A; Nakawuka M; Chiller TM; Boulware DR; Larson BA
PLoS One; 2019; 14(1):e0210105. PubMed ID: 30629619
[TBL] [Abstract][Full Text] [Related]
11. Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda.
Okongo M; Morgan D; Mayanja B; Ross A; Whitworth J
Int J Epidemiol; 1998 Aug; 27(4):698-702. PubMed ID: 9758128
[TBL] [Abstract][Full Text] [Related]
12. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.
Boulware DR; Meya DB; Muzoora C; Rolfes MA; Huppler Hullsiek K; Musubire A; Taseera K; Nabeta HW; Schutz C; Williams DA; Rajasingham R; Rhein J; Thienemann F; Lo MW; Nielsen K; Bergemann TL; Kambugu A; Manabe YC; Janoff EN; Bohjanen PR; Meintjes G;
N Engl J Med; 2014 Jun; 370(26):2487-98. PubMed ID: 24963568
[TBL] [Abstract][Full Text] [Related]
13. [Causes of death in patients with HIV infection in two Tunisian medical centers].
Chelli J; Bellazreg F; Aouem A; Hattab Z; Mesmia H; Lasfar NB; Hachfi W; Masmoudi T; Chakroun M; Letaief A
Pan Afr Med J; 2016; 25():105. PubMed ID: 28292068
[TBL] [Abstract][Full Text] [Related]
14. Six-month mortality among HIV-infected adults presenting for antiretroviral therapy with unexplained weight loss, chronic fever or chronic diarrhea in Malawi.
van Lettow M; Åkesson A; Martiniuk AL; Ramsay A; Chan AK; Anderson ST; Harries AD; Corbett E; Heyderman RS; Zachariah R; Bedell RA
PLoS One; 2012; 7(11):e48856. PubMed ID: 23185278
[TBL] [Abstract][Full Text] [Related]
15. Estimation of cause-specific mortality in Rakai, Uganda, using verbal autopsy 1999-2019.
Nabukalu D; Calazans JA; Marston M; Calvert C; Nakawooya H; Nansereko B; Sekubugu R; Nakigozi G; Serwadda D; Sewankambo N; Kigozi G; Gray RH; Nalugoda F; Makumbi F; Lutalo T; Todd J
Glob Health Action; 2024 Dec; 17(1):2338635. PubMed ID: 38717826
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis and tuberculosis/HIV/AIDS-associated mortality in Africa: the urgent need to expand and invest in routine and research autopsies.
Mudenda V; Lucas S; Shibemba A; O'Grady J; Bates M; Kapata N; Schwank S; Mwaba P; Atun R; Hoelscher M; Maeurer M; Zumla A
J Infect Dis; 2012 May; 205 Suppl 2():S340-6. PubMed ID: 22448024
[TBL] [Abstract][Full Text] [Related]
17. Natural history of opportunistic disease in an HIV-infected urban clinical cohort.
Moore RD; Chaisson RE
Ann Intern Med; 1996 Apr; 124(7):633-42. PubMed ID: 8607591
[TBL] [Abstract][Full Text] [Related]
18. Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa.
Nakanjako D; Kiragga AN; Musick BS; Yiannoutsos CT; Wools-Kaloustian K; Diero L; Oyaro P; Lugina E; Ssali JC; Kambugu A; Easterbrook P
AIDS; 2016 Jul; 30(12):1913-22. PubMed ID: 26959510
[TBL] [Abstract][Full Text] [Related]
19. Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes.
Haas AD; Zaniewski E; Anderegg N; Ford N; Fox MP; Vinikoor M; Dabis F; Nash D; Sinayobye JD; Niyongabo T; Tanon A; Poda A; Adedimeji AA; Edmonds A; Davies MA; Egger M;
J Int AIDS Soc; 2018 Feb; 21(2):. PubMed ID: 29479867
[TBL] [Abstract][Full Text] [Related]
20. Trends in one-year cumulative incidence of death between 2005 and 2013 among patients initiating antiretroviral therapy in Uganda.
Bebell LM; Siedner MJ; Musinguzi N; Boum Y; Bwana BM; Muyindike W; Hunt PW; Martin JN; Bangsberg DR
Int J STD AIDS; 2017 Jul; 28(8):800-807. PubMed ID: 27651351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
